Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Nutrients ; 13(1)2020 Dec 31.
Article in English | MEDLINE | ID: mdl-33396458

ABSTRACT

Both pre- and early postnatal supplementation with docosahexaenoic acid (DHA), arachidonic acid (AA) and folate have been related to neural development, but their long-term effects on later neural function remain unclear. We evaluated the long-term effects of maternal prenatal supplementation with fish-oil (FO), 5-methyltetrahydrofolate (5-MTHF), placebo or FO + 5-MTHF, as well as the role of fatty acid desaturase (FADS) gene cluster polymorphisms, on their offspring's processing speed at later school age. This study was conducted in NUHEAL children at 7.5 (n = 143) and 9 years of age (n = 127). Processing speed tasks were assessed using Symbol Digit Modalities Test (SDMT), Children Color Trails Test (CCTT) and Stroop Color and Word Test (SCWT). Long-chain polyunsaturated fatty acids, folate and total homocysteine (tHcy) levels were determined at delivery from maternal and cord blood samples. FADS and methylenetetrahydrofolate reductase (MTHFR) 677 C > T genetic polymorphisms were analyzed. Mixed models (linear and logistic) were performed. There were significant differences in processing speed performance among children at different ages (p < 0.001). The type of prenatal supplementation had no effect on processing speed in children up to 9 years. Secondary exploratory analyses indicated that children born to mothers with higher AA/DHA ratio at delivery (p < 0.001) and heterozygotes for FADS1 rs174556 (p < 0.05) showed better performance in processing speed at 9 years. Negative associations between processing speed scores and maternal tHcy levels at delivery were found. Our findings suggest speed processing development in children up to 9 years could be related to maternal factors, including AA/DHA and tHcy levels, and their genetic background, mainly FADS polymorphism. These considerations support that maternal prenatal supplementation should be quantitatively adequate and individualized to obtain better brain development and mental performance in the offspring.


Subject(s)
Child Development/physiology , Cognition/physiology , Dietary Supplements , Fatty Acid Desaturases/genetics , Maternal Nutritional Physiological Phenomena/physiology , Adult , Brain/growth & development , Child , Delta-5 Fatty Acid Desaturase , Docosahexaenoic Acids/administration & dosage , Docosahexaenoic Acids/blood , Fatty Acid Desaturases/metabolism , Female , Fetal Blood/chemistry , Follow-Up Studies , Homocysteine/blood , Humans , Infant Nutritional Physiological Phenomena/physiology , Infant, Newborn , Male , Maternal Age , Methylenetetrahydrofolate Reductase (NADPH2)/genetics , Multigene Family/genetics , Polymorphism, Genetic , Pregnancy , Stroop Test , Tetrahydrofolates/administration & dosage , Young Adult
2.
Am J Clin Nutr ; 103(1): 115-27, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26561619

ABSTRACT

BACKGROUND: During fetal and perinatal periods, many nutrients, such as long-chain polyunsaturated fatty acids [contained in fish oil (FO)] and folate, are important in achieving normal brain development. Several studies have shown the benefits of early nutrition on children's neurocognitive development. However, the evidence with regard to the attention system is scarce. OBJECTIVES: The aim of this study was to analyze the long-term effects of FO, 5-methyltetrahydrofolate (5-MTHF), or FO+5-MTHF prenatal supplementation on attention networks. DESIGN: Participants were 136 children born to mothers from the NUHEAL (Nutraceuticals for a Healthy Life) project (randomly assigned to receive FO and/or 5-MTHF or placebo prenatal supplementation) who were recalled for a new examination 8.5 y later. The response conflict-resolution ability (using congruent and incongruent conditions)), alerting, and spatial orienting of attention were evaluated with behavioral measures (Attention Network Test), electroencephalography/event-related potentials (ERPs), and standardized low-resolution brain electromagnetic tomography (sLORETA). RESULTS: Children born to mothers supplemented with 5-MTHF alone solved the response conflict more quickly than did the placebo and the FO+5-MTHF groups (all P < 0.05). Differences between ERP amplitudes for the conflict conditions were also observed. sLORETA analysis showed higher activation of the right midcingulate cortex for the incongruent condition. In addition, a significant slowing down of response speed depending on the warning cue in the 5-MTHF and FO groups was observed. CONCLUSIONS: Folate supplementation during pregnancy, rather than FO or FO+5-MTHF supplementation, improves children's ability to solve response conflicts. This advantage seems to be based on the higher activation of the midcingulate cortex, indicating that early nutrition influences the functionality of specific brain areas involved in executive functions. This trial was registered at clinicaltrials.gov as NCT01180933.


Subject(s)
Attention/physiology , Brain/growth & development , Dietary Fats, Unsaturated/pharmacology , Dietary Supplements , Executive Function/physiology , Prenatal Nutritional Physiological Phenomena , Tetrahydrofolates/pharmacology , Adult , Brain/physiology , Child , Child Development , Double-Blind Method , Female , Fetal Development , Fish Oils/pharmacology , Folic Acid/pharmacology , Humans , Male , Pregnancy , Vitamin B Complex/pharmacology
3.
Article in English | MEDLINE | ID: mdl-23502135

ABSTRACT

Health and nutrition modulate postnatal growth. The availability of amino acids and energy, and insulin and insulin-like growth factor-I (IGF-I) regulates early growth through the mTOR pathway. Amino acids and glucose also stimulate the secretion of IGF-I and insulin. Postnatal growth induces lasting, programming effects on later body size and adiposity in animals and in human observational studies. Rapid weight gain in infancy and the first 2 years was shown to predict increased obesity risk in childhood and adulthood. Breastfeeding leads to lesser high weight gain in infancy and reduces obesity risk in later life by about 20%, presumably partly due to the lower protein supply with human milk than conventional infant formula. In a large randomized clinical trial, we tested the hypothesis that reduced infant formula protein contents lower insulin-releasing amino acid concentrations and thereby decrease circulating insulin and IGF-I levels, resulting in lesser early weight gain and reduced later obesity risk (the 'Early Protein Hypothesis'). The results demonstrate that lowered protein in infant formula induces similar - but not equal - metabolic and endocrine responses and normalizes weight and BMI relative to breastfed controls at the age of 2 years. The results available should lead to enhanced efforts to actively promote, protect and support breastfeeding. For infants that are not breastfed or not fully breastfed, the use of infant formulas with lower protein contents but high protein quality appears preferable. Cows' milk as a drink provides high protein intake and should be avoided in infancy.


Subject(s)
Breast Feeding , Infant Formula , Infant Nutritional Physiological Phenomena , Milk, Human , Amino Acids/blood , Amino Acids, Branched-Chain/blood , Animals , Blood Glucose/analysis , Body Mass Index , C-Peptide/urine , Dietary Proteins/administration & dosage , Humans , Infant , Insulin/blood , Insulin-Like Growth Factor Binding Protein 3/blood , Insulin-Like Growth Factor I/analysis , Insulin-Like Growth Factor I/metabolism , Milk , Nutritional Status , Obesity/prevention & control , RNA-Binding Proteins/blood , Risk Factors , Urea/blood , Weight Gain/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...